文献速递治疗药物监测与药物基因组学特殊人群用药

实体器官移植中他克莫司膜转运蛋白的药物遗传学

Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.
PubMed 文献 · Clin Pharmacokinet · 2019-01-01

本文综述了膜转运蛋白药物遗传学与他克莫司药代动力学个体间变异及毒性发生的关系。多个转运蛋白基因变异(如ABCB1、ABCC2、ABCC8、SLC30A8、SLCO1B1/3等)与他克莫司药代动力学变异或毒性相关,但体内影响仍存争议,需更大队列验证。

要点

  • 多个膜转运蛋白基因变异与他克莫司药代动力学变异或毒性相关。
  • 这些变异在体内的影仍有争议,需更大队列研究验证。
  • 转运蛋白多态性与他克莫司细胞内浓度的关系需进一步研究。

核心结论

  • 膜转运蛋白药物遗传学是探索他克莫司临床药理学有前景的领域。
  • 多个转运蛋白基因变异与他克莫司药代动力学变异或毒性相关,但体内影响仍存争议。

研究设计与样本

  • 综述,旨在总结目前关于膜转运蛋白药物遗传学可能参与他克莫司反应个体间变异的数据。

主要发现

  • 编码 influx 或 efflux 膜转运蛋白的基因(如ABCB1、ABCC2、ABCC8、SLC30A8、SLCO1B1/3、SLC28A1、SLC22A11和SLC28A3)的多个遗传变异与他克莫司药代动力学变异或毒性发生相关。
  • 这些变异在体内的影仍有争议,需更大队列研究确认并在实体器官移植中验证这些遗传生物标志物对免疫抑制治疗个体化的相关性。

局限性

  • 这些变异在体内的影仍有争议,需更大队列研究确认。
  • 转运蛋白多态性与他克莫司细胞内浓度的关系需进一步研究。
  • 主要挑战可能是阐明导致药物浓度或临床效应改变的遗传变异背后生物学机制的相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Membrane transporters play an essential role in the pharmacokinetics of drugs as they mediate exchanges between biological compartments. Tacrolimus is characterized by wide interpatient variability in terms of its pharmacokinetics that may in part be due to genetic factors. The pharmacogenetics of drug transporters is therefore a promising area to explore in the clinical pharmacology of tacrolimus. The aim of this review is to provide an overview of currently available data regarding the pharmacogenetics of membrane transporters that may be involved in the interindividual variability of the response to tacrolimus. Several genetic variants in genes coding for influx or efflux membrane transporters (e.g. ABCB1, ABCC2, ABCC8, SLC30A8, SLCO1B1/3, SLC28A1, SLC22A11, and SLC28A3) have been associated with tacrolimus pharmacokinetics variability or the occurrence of toxicity; however, there is still a degree of controversy as to the impact of these variants in vivo and further investigations are needed to confirm these results in larger cohorts and to validate the relevance of such genetic biomarkers for personalization of immunosuppressive therapy in solid organ transplantations. The relationship between transporter polymorphisms and the intracellular concentration of tacrolimus should also be further investigated. Finally, the main challenge could be elucidation of the interplay of biological mechanisms underlying genetic variations that alter the drug concentration or its clinical effect.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Tron C, Lemaitre F, Verstuyft C, et al. Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation. Clin Pharmacokinet. 2019. PMID: 30415459. doi:10.1007/s40262-018-0717-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。